Dimension Therapeutics Analysts Recommendations and Consensus

Dimension Therapeutics Inc -- USA Stock  

USD 6  0.03  0.5%

The current analyst and expert consensus on Dimension Therapeutics is Buy with 0 strong sell and 2 strong buy opinions. The current projected target price consensus is 16.33 with 3 analysts opinions. The most common way Dimension Therapeutics analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Dimension Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Dimension Therapeutics. We encourage you to use your own analysis of Dimension Therapeutics to validate this buy or sell advice. Dimension Therapeutics buy or sell recommendation module provides average expert sentiment on the projected Dimension Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 13.65. Additionally see Macroaxis Advice on Dimension Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Dimension Therapeutics Target Price Consensus

Number of Opinions4
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Current Price

Dimension Therapeutics Market Quote
Low Price5.95Odds
High Price6.0Odds

6.0

Target Price

Analyst Consensus On Target Price
Low Estimate7.0Odds
High Estimate32.0Odds
Number of Analysts3
Standard Deviation13.65

16.333

Dimension Therapeutics Analysit Ratings

Average Consensus